These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17455644)

  • 21. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of refractory infections--selection and application of anti-microbial agents].
    Nihon Rinsho; 1988 Jul; 46 Suppl():345-89. PubMed ID: 3271255
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nursing home as a risky environment when it comes to antibiotic resistance. An audit study of antibiotic treatment at nursing homes in Kronoberg].
    Lonér B; Petersson C; Cars H; Ovhed I
    Lakartidningen; 2000 Mar; 97(11):1251-4. PubMed ID: 10771542
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemical structure , anti-bacterial activity and pharmacokinetics of new quinolones].
    Matsumoto F; Nishiwaki K; Morita M
    Nihon Rinsho; 1991 Oct; 49(10):2291-8. PubMed ID: 1660945
    [No Abstract]   [Full Text] [Related]  

  • 25. Minocycline administered intravenously: pharmacological activity and clinical experience.
    Clark BJ; Hodgson CR; Dornbush AC; Hutchinson J
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):865-77. PubMed ID: 4214661
    [No Abstract]   [Full Text] [Related]  

  • 26. [In common infections: to give or not to give antibiotics].
    Mölstad S; André M; Norman C; Hedin K; Engström S
    Lakartidningen; 2009 Nov 18-24; 106(47):3162-4, 3166. PubMed ID: 20077641
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selection between oral and injection routes of antibiotic therapy for respiratory infections based on clinical observations].
    Kitsukawa K
    Nihon Naika Gakkai Zasshi; 1998 Feb; 87(2):254-8. PubMed ID: 9549320
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activity of a new semisynthetic penicillin derivative: piperacillin. Clinical and experimental research].
    Romeo R; Sorace R; Libertini C; Santangelo C; Patanè S; Di Stefano F; Gatto A
    G Ital Chemioter; 1981; 28(1-2):61-4. PubMed ID: 6751918
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical and bacteriologic experimentation with cephradine in pediatrics].
    Malherbe A
    Brux Med; 1974 Feb; 54(2):99-103. PubMed ID: 4434245
    [No Abstract]   [Full Text] [Related]  

  • 30. Prulifloxacin: a new antibacterial fluoroquinolone.
    Prats G; Rossi V; Salvatori E; Mirelis B
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):27-41. PubMed ID: 16441207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selecting an oral broad-spectrum antibiotic.
    Poole MD
    Ear Nose Throat J; 1992 Sep; 71(9):444-5. PubMed ID: 1425385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Best use of drugs. B. Use of antibiotics. 10/ Otorhinolaryngologic infections].
    Legat C; Mandy B; Woronoff-Lemsi MC
    Soins; 2003 Jun; (676):55-6. PubMed ID: 12852278
    [No Abstract]   [Full Text] [Related]  

  • 33. Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection.
    Beale AS; Masson ND
    J Antimicrob Chemother; 1994 Dec; 34(6):1072-4. PubMed ID: 7730224
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of the quinolones.
    Andersson MI; MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New methods of administration of cephalosporins and aminoglycosides: relations between pharmacokinetics and pharmacodynamics].
    Kamnev IuV
    Antibiot Khimioter; 1992 Feb; 37(2):44-50. PubMed ID: 1514855
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of urinary tract infection].
    Graninger W; Presterl E; Radosztics S; Thalhammer F; Emminger W
    Wien Med Wochenschr; 1991; 141(23-24):544-51. PubMed ID: 1810094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter research on the clinical effectiveness and tolerability of an antibacterial drug. Results of 1063 cases].
    Privitera G; Bonino S; Del Mastro S
    Clin Ter; 1982 Apr; 101(2):123-36. PubMed ID: 7094544
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging drugs for bacterial urinary tract infections.
    Wagenlehner FM; Weidner W; Perletti G; Naber KG
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):375-97. PubMed ID: 20569081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacterial flora in nontuberculous infections of the respiratory tract (findings relevant to the year 1988)].
    Saviano G; Borrelli G; Cerbone V; Ferrera P; La Gala F; Cuccurullo S; Corsi G
    Arch Monaldi Mal Torace; 1988; 43(6):475-85. PubMed ID: 3155011
    [No Abstract]   [Full Text] [Related]  

  • 40. [Urinary tract infections caused by Pseudomonas aeruginosa].
    Ohi Y; Goto T; Mizuma Y
    Nihon Rinsho; 1991 Oct; 49(10):2323-30. PubMed ID: 1660946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.